TQF6422
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 01, 2026
A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.
(clinicaltrials.gov)
- P1 | N=108 | Not yet recruiting | Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
New P1 trial • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1